Opinion: Shortages of generic drugs can’t be blamed solely on group purchasing organizations
STAT
APRIL 25, 2024
More than 90% of prescriptions filled that year were for generics or biosimilars, up from just over 18% the year that Hatch-Waxman was passed. Important categories of drugs — from antibiotics to chemotherapies to saline solution — experience persistent shortages and inadequate quality.
285 
Let's personalize your content